NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,666,777 | -61.1% | 350,884 | 0.0% | 3.55% | -54.4% |
| Q2 2023 | $14,561,686 | -31.0% | 350,884 | 0.0% | 7.79% | -43.3% |
| Q1 2023 | $21,102,164 | -18.0% | 350,884 | 0.0% | 13.74% | +0.4% |
| Q4 2022 | $25,737,341 | -3.5% | 350,884 | 0.0% | 13.70% | -6.4% |
| Q3 2022 | $26,660,000 | +9.3% | 350,884 | 0.0% | 14.63% | -0.6% |
| Q2 2022 | $24,386,000 | -16.1% | 350,884 | 0.0% | 14.72% | +13.8% |
| Q1 2022 | $29,071,000 | +10.4% | 350,884 | 0.0% | 12.94% | +61.6% |
| Q4 2021 | $26,344,000 | -35.4% | 350,884 | 0.0% | 8.01% | -26.7% |
| Q3 2021 | $40,762,000 | -47.6% | 350,884 | 0.0% | 10.92% | -29.6% |
| Q2 2021 | $77,833,000 | +67.8% | 350,884 | 0.0% | 15.51% | +45.9% |
| Q1 2021 | $46,380,000 | -23.6% | 350,884 | 0.0% | 10.63% | -58.1% |
| Q4 2020 | $60,717,000 | +55.5% | 350,884 | 0.0% | 25.38% | +35.1% |
| Q3 2020 | $39,057,000 | +39.9% | 350,884 | -25.5% | 18.79% | +86.2% |
| Q2 2020 | $27,923,000 | -11.9% | 470,884 | 0.0% | 10.09% | -35.2% |
| Q1 2020 | $31,709,000 | -20.1% | 470,884 | 0.0% | 15.57% | -22.6% |
| Q4 2019 | $39,681,000 | – | 470,884 | – | 20.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |